STFC-funded hybrid technology, evolved from space physics, combines gamma and optical imaging to improve the accuracy of cancer diagnosis.
Sentinel node biopsy is routinely used for cancer staging. This procedure is usually carried out using a non-imaging, gamma probe which detects a radioactive tracer injected inside the body to search for any abnormalities within the system. This is done during surgery. Since a non-imaging probe is used, the nodes can be missed, leading to misdiagnosis. With over 1,383,000 worldwide incidence of breast cancer and 277,000 worldwide incidence of pancreatic cancer, new cameras will improve and reduce the cost of cancer detection.